Question 1

What is the catalog number for Txn2 Mouse Gene Knockout Kit (CRISPR)?

Accepted Answer

The catalog number for Txn2 Mouse Gene Knockout Kit (CRISPR) is KN318507BN.

Question 2

What sizes are available for Txn2 Mouse Gene Knockout Kit (CRISPR)?

Accepted Answer

Txn2 Mouse Gene Knockout Kit (CRISPR) is available in the following size(s): 1 Kit.

Question 3

Is Txn2 Mouse Gene Knockout Kit (CRISPR) in stock?

Accepted Answer

Txn2 Mouse Gene Knockout Kit (CRISPR) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Txn2 Mouse Gene Knockout Kit (CRISPR)?

Accepted Answer

The safety data sheet for Txn2 Mouse Gene Knockout Kit (CRISPR) is available here: https://cdn.origene.com/sds/kn318507bn.pdf.

Question 5

What is Txn2 Mouse Gene Knockout Kit (CRISPR) used for?

Accepted Answer

Txn2 - mouse gene knockout kit via CRISPR, HDR mediated

Question 6

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

Question 7

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Question 8

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Txn2 Mouse Gene Knockout Kit (CRISPR)

Product Specifications

UniProt

Gene Location

Symbol

Frequently Asked Questions

Explore Other Products

Human JAK2 activation kit by CRISPRa

TNNT3 (NM_006757) Human Over-expression Lysate

CD31 / PECAM-1 (C31.3), CF647 conjugate, 0.1mg/mL

Palmitoleic Acid

Fluorodifen-d4

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, 0.1mg/mL